Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • Patient Termination Requires Right Steps, Good Documentation

    Terminating a relationship with a patient or banning someone from a hospital is never done lightly, and, fortunately, it does not happen often. But when it is necessary, healthcare organizations must tread carefully to ensure that the patient is afforded other opportunities and that the potential liabilities are minimized.

  • Patient Advocacy System Shown to Lower Malpractice Costs

    A patient advocacy reporting program at Vanderbilt University Medical Center was associated with a significant decrease in malpractice claim costs for high-risk clinicians in an orthopedic practice network, suggesting a strategy that other hospitals can employ.

  • HITECH Audits Return: OCR Promises Enforcement Changes for HIPAA

    The Health and Human Services Office for Civil Rights (HHS OCR) has reopened the Health Information Technology for Economic and Clinical Health (HITECH) audit program and will begin audits of HIPAA-regulated entities later in 2024. The audits will focus on the Security Rule, particularly the requirements for security risk analyses and risk management.

  • Disorders of Immunity Are a Risk Factor for Herpes Simplex Virus Encephalitis

    The current study of herpes simplex virus (HSV) encephalitis demonstrated an association of encephalitis with preexisting autoimmune disease and/or exposure to immunosuppressive and immunomodulatory medications. The findings underscore the potential underestimation of antecedent immune-related dysregulation in HSV encephalitis cases to date.

  • Efgartigimod for Seronegative Myasthenia Gravis

    In an uncontrolled, open-label series of patients with myasthenia gravis, double antibody-negative patients responded to immunosuppressive therapies in a similar manner as do those with antibodies to acetylcholine receptors (AChR) or muscle-specific tyrosine kinase. However, when treating myasthenia patients with a specific agent (efgartigimod) that blocks AChR antibodies at the level of endothelial cells, double antibody-negative patients do not respond as well.

  • Usefulness of the Physical Examination in the Concussed Patient

    This article suggests that certain specific physical examination findings may be helpful in evaluating and monitoring patients with sports-related concussion using oculovestibular responses and balance tests.

  • Intensive Lifestyle Interventions May Prevent and Ameliorate the Symptoms Alzheimer’s Disease

    Recent clinical studies support the benefit of intensive lifestyle interventions, which should include a plant-based diet, exercise, stress management, and avoidance of smoking and alcohol, for the prevention of Alzheimer’s disease.

  • Non-Marine Envenomations in the United States

    Envenomations can be caused by many different species, both marine and non-marine. The presentation can range from minor skin irritation to anaphylaxis, systemic illness, organ failure, and even death. Knowing which species are endemic to the area, and what the presentations of medically important envenomations will look like, can aid in recognition and timely treatment, especially when the bite or sting was unwitnessed. This article will give an overview of medically important non-marine envenomations in the United States, including their clinical manifestations, treatment, and disposition.

  • Doxycycline After Sex

    Single-dose doxycycline is recommended after oral, vaginal, or anal sex in selected high-risk individuals.

  • Cefepime and Enmetazobactam Injection (Exblifep)

    The U.S. Food and Drug Administration has approved the combination of cefepime and enmetazobactam (FPE) for the treatment of complicated urinary tract infections (cUTIs).